Pivotal role of the endoplasmic reticulum stress-related XBP1s/miR-22/SIRT1 axis in acute myeloid leukemia apoptosis and response to chemotherapy.
Journal
Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895
Informations de publication
Date de publication:
22 Jun 2024
22 Jun 2024
Historique:
received:
19
01
2024
accepted:
17
06
2024
revised:
13
06
2024
medline:
23
6
2024
pubmed:
23
6
2024
entrez:
22
6
2024
Statut:
aheadofprint
Résumé
Malignant growth relies on rapid protein synthesis frequently leading to endoplasmic reticulum (ER) overload and accumulation of unfolded or misfolded protein in this cellular compartment. In the ER, protein homeostasis is finely regulated by a mechanism called the unfolded protein response (UPR), involving the activation of signalization pathways mediated by three transmembrane proteins, namely PERK, IRE1 and ATF6. IRE1 endoribonuclease activation leads in particular to the splicing of the cytosolic mRNA encoding the key UPR-specific transcription factor XBP1s. Our study shows that sustained activation of XBP1s expression in acute myeloid leukemia (AML) cells induces apoptosis in vitro and in vivo, whereas a moderate XBP1s expression sensitizes cells to chemotherapeutic treatments. ChIP-seq experiments identified specific XBP1s target genes including the MIR22HG lncRNA, the precursor transcript of microRNA-22-3p. miR-22-3p upregulation by XBP1s or forced expression of miR-22 significantly decreases cell's viability and sensitizes leukemic cells to chemotherapy. We found that miR-22-3p intracellular effects result at least partially from the targeting of the mRNA encoding the deacetylase sirtuin-1 (SIRT1), a well-established pro-survival factor. Therefore, this novel XBP1s/miR-22/SIRT1 axis identified could play a pivotal role in the proliferation and chemotherapeutic response of leukemic cells.
Identifiants
pubmed: 38909090
doi: 10.1038/s41375-024-02321-8
pii: 10.1038/s41375-024-02321-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Association Laurette Fugain (Laurette Fugain)
ID : ALF2018/03
Organisme : Kay Kendall Leukaemia Fund (KKLF)
ID : KKL1149
Organisme : Academy of Medical Sciences
ID : SBF004\1099
Pays : United Kingdom
Informations de copyright
© 2024. The Author(s).
Références
Moon HW, Han HG, Jeon YJ. Protein quality control in the endoplasmic reticulum and cancer. Int J Mol Sci. 2018;19:3020.
pubmed: 30282948
pmcid: 6213883
doi: 10.3390/ijms19103020
Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13:89–102.
pubmed: 22251901
doi: 10.1038/nrm3270
Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol cell. 2018;69:169–81.
pubmed: 29107536
doi: 10.1016/j.molcel.2017.06.017
Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21:421–38.
pubmed: 32457508
pmcid: 8867924
doi: 10.1038/s41580-020-0250-z
Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519–29.
pubmed: 17565364
doi: 10.1038/nrm2199
Hetz C, Chevet E. Theme Series-UPR in cancer. Semin Cancer Biol. 2015;33:1–2.
pubmed: 25957480
doi: 10.1016/j.semcancer.2015.04.008
Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999;13:1211–33.
pubmed: 10346810
doi: 10.1101/gad.13.10.1211
Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, et al. IRE1 signaling affects cell fate during the unfolded protein response. Science. 2007;318:944–9.
pubmed: 17991856
pmcid: 3670588
doi: 10.1126/science.1146361
Shamu CE, Walter P. Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J. 1996;15:3028–39.
pubmed: 8670804
pmcid: 450244
doi: 10.1002/j.1460-2075.1996.tb00666.x
Maurel M, Chevet E, Tavernier J, Gerlo S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci. 2014;39:245–54.
pubmed: 24657016
doi: 10.1016/j.tibs.2014.02.008
Hollien J, Weissman JS. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science. 2006;313:104–7.
pubmed: 16825573
doi: 10.1126/science.1129631
Glimcher LH. XBP1: the last two decades. Ann Rheum Dis. 2010;69:i67–71.
pubmed: 19995749
doi: 10.1136/ard.2009.119388
Lu Y, Liang FX, Wang X. A synthetic biology approach identifies the mammalian UPR RNA ligase RtcB. Mol Cell. 2014;55:758–70.
pubmed: 25087875
pmcid: 4156904
doi: 10.1016/j.molcel.2014.06.032
Peschek J, Acosta-Alvear D, Mendez AS, Walter P. A conformational RNA zipper promotes intron ejection during non-conventional XBP1 mRNA splicing. EMBO Rep. 2015;16:1688–98.
pubmed: 26483401
pmcid: 4687415
doi: 10.15252/embr.201540955
Yamamoto K, Sato T, Matsui T, Sato M, Okada T, Yoshida H, et al. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev Cell. 2007;13:365–76.
pubmed: 17765680
doi: 10.1016/j.devcel.2007.07.018
Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Mori K. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J Biochem. 2004;136:343–50.
pubmed: 15598891
doi: 10.1093/jb/mvh122
Acosta-Alvear D, Karagoz GE, Frohlich F, Li H, Walther TC, Walter P. The unfolded protein response and endoplasmic reticulum protein targeting machineries converge on the stress sensor IRE1. Elife. 2018;7:e43036.
Feral K, Jaud M, Philippe C, Di Bella D, Pyronnet S, Rouault-Pierre K, et al. ER stress and unfolded protein response in leukemia: friend, foe, or both? Biomolecules. 2021;11:199.
Bujisic B, De Gassart A. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth. Blood. 2017;129:2420–8.
pubmed: 28167662
doi: 10.1182/blood-2016-09-741348
Schardt JA, Mueller BU, Pabst T. Activation of the unfolded protein response in human acute myeloid leukemia. Methods Enzymol. 2011;489:227–43.
pubmed: 21266233
doi: 10.1016/B978-0-12-385116-1.00013-3
Schardt JA, Weber D, Eyholzer M, Mueller BU, Pabst T. Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15:3834–41.
doi: 10.1158/1078-0432.CCR-08-2870
Sun H, Lin DC, Guo X, Kharabi Masouleh B, Gery S, Cao Q, et al. Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget. 2016;7:18736–49.
pubmed: 26934650
pmcid: 4951325
doi: 10.18632/oncotarget.7702
Liu L, Zhao M, Jin X, Ney G, Yang KB, Peng F, et al. Adaptive endoplasmic reticulum stress signalling via IRE1α-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells. Nat Cell Biol. 2019;21:328–37.
pubmed: 30778220
pmcid: 6745703
doi: 10.1038/s41556-019-0285-6
Jiang X, Hu C, Arnovitz S, Bugno J, Yu M, Zuo Z, et al. miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun. 2016;7:11452.
pubmed: 27116251
pmcid: 5477496
doi: 10.1038/ncomms11452
Lee JH, Park SJ, Jeong SY, Kim MJ, Jun S, Lee HS, et al. MicroRNA-22 suppresses DNA repair and promotes genomic instability through targeting of MDC1. Cancer Res. 2015;75:1298–310.
pubmed: 25627978
doi: 10.1158/0008-5472.CAN-14-2783
Zhang X, Li Y, Wang D, Wei X. miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1. Biol Res. 2017;50:27.
pubmed: 28882183
pmcid: 5590131
doi: 10.1186/s40659-017-0133-8
Touriol C, Roussigne M, Gensac MC, Prats H, Prats AC. Alternative translation initiation of human fibroblast growth factor 2 mRNA controlled by its 3′-untranslated region involves a Poly(A) switch and a translational enhancer. J Biol Chem. 2000;275:19361–7.
pubmed: 10858460
doi: 10.1074/jbc.M908431199
Philippe C, Dubrac A, Quelen C, Desquesnes A, Van Den Berghe L, Ségura C, et al. PERK mediates the IRES-dependent translational activation of mRNAs encoding angiogenic growth factors after ischemic stress. Sci Signal. 2016;9:ra44.
pubmed: 27141928
doi: 10.1126/scisignal.aaf2753
Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003;23:7448–59.
pubmed: 14559994
pmcid: 207643
doi: 10.1128/MCB.23.21.7448-7459.2003
Shen T, Li Y, Liang S, Chen Z. XBP1 negatively regulates CENPF expression via recruiting ATF6α to the promoter during ER stress. Cancer Cell Int. 2020;20:459.
pubmed: 32973403
pmcid: 7507253
doi: 10.1186/s12935-020-01553-9
Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, et al. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell. 2007;27:53–66.
pubmed: 17612490
doi: 10.1016/j.molcel.2007.06.011
Pramanik J, Chen X, Kar G, Henriksson J, Gomes T, Park JE, et al. Genome-wide analyses reveal the IRE1a-XBP1 pathway promotes T helper cell differentiation by resolving secretory stress and accelerating proliferation. Genome Med. 2018;10:76.
pubmed: 30355343
pmcid: 6199730
doi: 10.1186/s13073-018-0589-3
Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res. 2013;112:1234–43.
pubmed: 23524588
pmcid: 3720677
doi: 10.1161/CIRCRESAHA.112.300682
Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol. 2011;193:409–24.
pubmed: 21502362
pmcid: 3080260
doi: 10.1083/jcb.201010100
Sasca D, Hähnel PS, Szybinski J, Khawaja K, Kriege O, Pante SV, et al. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood. 2014;124:121–33.
pubmed: 24855208
doi: 10.1182/blood-2013-11-538819
Li L, Osdal T, Ho Y, Chun S, McDonald T, Agarwal P, et al. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell. 2014;15:431–46.
pubmed: 25280219
pmcid: 4305398
doi: 10.1016/j.stem.2014.08.001
Li L, Bhatia R. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells. Curr Opin Hematol. 2015;22:324–9.
pubmed: 26049753
pmcid: 4482757
doi: 10.1097/MOH.0000000000000152
Rufo N, Yang Y, De Vleeschouwer S, Agostinis P. The “Yin and Yang” of unfolded protein response in cancer and immunogenic cell death. Cells. 2022;11:2899.
Kharabi Masouleh B, Geng H, Hurtz C, Chan LN, Logan AC, Chang MS, et al. Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2014;111:E2219–2228.
pubmed: 24821775
pmcid: 4040579
doi: 10.1073/pnas.1400958111
Xie H, Tang CH, Song JH, Mancuso A, Del Valle JR, Cao J, et al. IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers. J Clin Investig. 2018;128:1300–16.
pubmed: 29381485
pmcid: 5873889
doi: 10.1172/JCI95864
Gebert M, Sobolewska A, Bartoszewska S, Cabaj A, Crossman DK, Kroliczewski J, et al. Genome-wide mRNA profiling identifies X-box-binding protein 1 (XBP1) as an IRE1 and PUMA repressor. Cell Mol Life Sci. 2021;78:7061–80.
pubmed: 34636989
pmcid: 8558229
doi: 10.1007/s00018-021-03952-1
Ghosh R, Wang L, Wang ES, Perera BG, Igbaria A, Morita S, et al. Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress. Cell. 2014;158:534–48.
pubmed: 25018104
pmcid: 4244221
doi: 10.1016/j.cell.2014.07.002
Bartoszewska S, Slawski J, Collawn JF, Bartoszewski R. Dual RNase activity of IRE1 as a target for anticancer therapies. J Cell Commun Signal. 2023;17:1145–61.
Liu X, Wu B, Chen H, Sun H, Guo X, Sun T, et al. Intense endoplasmic reticulum stress (ERS) / IRE1α enhanced Oxaliplatin efficacy by decreased ABCC10 in colorectal cancer cells. BMC Cancer. 2022;22:1369.
pubmed: 36585626
pmcid: 9805014
doi: 10.1186/s12885-022-10415-8
Zeng T, Peng L, Chao H, Xi H, Fu B, Wang Y, et al. IRE1α-TRAF2-ASK1 complex-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to CXC195-induced apoptosis in human bladder carcinoma T24 cells. Biochem Biophys Res Commun. 2015;460:530–6.
pubmed: 25797626
doi: 10.1016/j.bbrc.2015.03.064
Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287:664–6.
pubmed: 10650002
doi: 10.1126/science.287.5453.664
Fink EE, Moparthy S, Bagati A, Bianchi-Smiraglia A, Lipchick BC, Wolff DW, et al. XBP1-KLF9 axis acts as a molecular rheostat to control the transition from adaptive to cytotoxic unfolded protein response. Cell Rep. 2018;25:212–223 e214.
pubmed: 30282030
pmcid: 6251307
doi: 10.1016/j.celrep.2018.09.013
Zhang XT, Hu XB, Wang HL, Kan WJ, Xu L, Wang ZJ, et al. Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma. Acta Pharmacol Sin. 2021;42:814–23.
pubmed: 32855532
doi: 10.1038/s41401-020-00505-3
Voellenkle C, Garcia-Manteiga JM, Pedrotti S, Perfetti A, De Toma I, Da Silva D, et al. Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep. 2016;6:24141.
pubmed: 27063004
pmcid: 4827084
doi: 10.1038/srep24141
Tani H, Onuma Y, Ito Y, Torimura M. Long non-coding RNAs as surrogate indicators for chemical stress responses in human-induced pluripotent stem cells. PLoS ONE. 2014;9:e106282.
pubmed: 25171338
pmcid: 4149554
doi: 10.1371/journal.pone.0106282
Wang J, Li Y, Ding M, Zhang H, Xu X, Tang J. Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (review). Int J Oncol. 2017;50:345–55.
pubmed: 28000852
doi: 10.3892/ijo.2016.3811
Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell. 2013;13:87–101.
pubmed: 23827711
pmcid: 3767186
doi: 10.1016/j.stem.2013.06.003
Song SJ, Pandolfi PP. miR-22 in tumorigenesis. Cell Cycle. 2014;13:11–12.
pubmed: 24231768
doi: 10.4161/cc.27027
Chalkiadaki A, Guarente L. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer. 2015;15:608–24.
pubmed: 26383140
doi: 10.1038/nrc3985
Chang CJ, Hsu CC, Yung MC, Chen KY, Tzao C, Wu WF, et al. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem Biophys Res Commun. 2009;380:236–42.
pubmed: 19166820
doi: 10.1016/j.bbrc.2009.01.040
Sun Y, Sun D, Li F, Tian L, Li C, Li L, et al. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. Lung Cancer. 2007;58:21–29.
pubmed: 17624472
doi: 10.1016/j.lungcan.2007.05.013
Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS, et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol. 2006;26:28–38.
pubmed: 16354677
pmcid: 1317617
doi: 10.1128/MCB.26.1.28-38.2006
Li Y, Xu S, Giles A, Nakamura K, Lee JW, Hou X, et al. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J Off Publ Fed Am Soc Exp Biol. 2011;25:1664–79.
Wang FM, Chen YJ, Ouyang HJ. Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation. Biochem J. 2011;433:245–52.
pubmed: 20955178
doi: 10.1042/BJ20101293